Zydus Lifesciences Ltd Quarterly Results
Q2 FY25-26 Results Summary
Revenue
The revenue stands at ₹6,123.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.85 per cent from ₹6,573.70 crore. This corresponds to a year-on-year *(YoY) growth of 16.92 per cent.
Operating Profit
Operating Profit stands at ₹210.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.23 per cent from ₹239.60 crore. This corresponds to a year-on-year *(YoY) growth of 124.68 per cent.
PBDT
PBDT stands at ₹755.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.47 per cent from ₹672.10 crore. This corresponds to a year-on-year *(YoY) growth of 24.59 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,692.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.42 per cent from ₹1,955.00 crore. This corresponds to a year-on-year *(YoY) growth of 30.87 per cent.
Net Profit
Net Profit stands at ₹1,292.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.86 per cent from ₹1,466.80 crore. This represents a 41.93 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Zydus Lifesciences Ltd News
Zydus Lifesciences Ltd Earnings
- YOY
- QOQ
Zydus Lifesciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Zydus Lifesciences Ltd Research Reports
Zydus Lifesciences Ltd Financial Reports
Zydus Lifesciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Zydus Lifesci. | 1.29% | -0.57% | -4.27% | -12.09% | -9.36% | -10.83% |
| Cipla | -0.85% | -3.39% | -8.36% | -16.70% | -6.07% | -2.89% |
| Lupin | 0.08% | -0.77% | 2.44% | 12.07% | 13.34% | 3.55% |
| Dr Reddy's Labs | -0.77% | -1.69% | -9.14% | -9.55% | -7.39% | -9.47% |
| Mankind Pharma | -2.68% | -5.62% | -3.19% | -13.44% | -19.98% | -17.38% |
| Alkem Lab | -1.89% | -1.78% | 1.88% | 3.15% | 14.54% | 10.61% |
| Aurobindo Pharma | -0.44% | -1.11% | -4.66% | 6.01% | 2.53% | -1.64% |
Company Info
Company Information
Chairman (Non-Executive) : Pankaj R Patel
Managing Director : Sharvil P Patel
Non Executive Director : Mukesh M Patel
Independent Director : Apurva S Diwanji
Whole-time Director : Ganesh N Nayak
Independent Director : Bhadresh K Shah
Company Sec. & Compli. Officer : Dhaval N Soni
Independent Director : Akhil A. Monappa
Independent Director : Upasana Konidela.
Independent Director : Shelina P. Parikh